NL-OMON39498撤回不适用
A prospective single-blinded randomized multi-center clinical trial comparing the clinical efficacy and patient acceptability of open selective haemorrhoidopexy with stapled haemorrhoidopexy - PILE STOP Study
Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 186 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 发起方
- 入组人数
- 186
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99(—)
入选标准
- •Age above 18 years;Symptoms of haemorrhoidal disease 2nd to 4th grade. In case of 2nd grade haemorrhoidal disease, at least two attempts of Barron ligation must have preceded;Primary or recurrent haemorrhoidal disease;Written informed consent
排除标准
- •Acute presentation (not elective)
- •Concurrent untreated or recurrent colorectal cancer
- •Concomitant anorectal diseases (fistula, abscess, fissure, polyps)
- •Prior endoscopic or surgical treatment of haemorrhoids within the past 6 months
- •Active inflammatory bowel disease
- •Previous major anorectal surgery
- •A history of faecal incontinence
- •Presence of severe rectal pain
- •The patient is uncooperative or is not capable to return for routine outpatient follow-up
- •On Coumarine derivate anticoagulation or history of coagulopathy
- •On immunosuppressant medication
- •Non-consenting patients
- •Unwilling for randomisation
研究者
相似试验
进行中(未招募)
1 期
A prospective randomized, single-blind, multicenter phase II study comparing two methods of cardioplegia in cardiac surgery due to congenital heart malformation in children: Custodiol-N versus Custodiol (CL-N-CP-Paed-II/09/19)congenital heart malformation inchildrenCTIS2024-511517-38-00Dr. Franz Koehler Chemie GmbH100
招募中
3 期
A prospective, randomized, single blind, multicentre phase III study on organ preservation with Custodiol-N solution compared with Custodiol solution in or-gan transplantation (kidney, liver and pancreas)2024-512444-29-00Dr. Franz Koehler Chemie GmbH362
进行中(未招募)
1 期
A Prospective, randomized, single blind, multicenter Phase III study of organ perfusion with Custodiol-N solution compared with Custodiol solution in Heart transplantatioEUCTR2012-001112-29-DEDr. Franz Köhler Chemie GmbH
进行中(未招募)
1 期
A Prospective, randomized, single blind, multicenter Phase III study of organ perfusion with Custodiol-N solution compared with Custodiol solution in Heart transplantatioEUCTR2012-001112-29-ATFa. Dr. Franz Köhler Chemie GmbH
进行中(未招募)
1 期
A Phase 3 study to evaluate whether macitentan 75 mg is an effective and safe treatment for patients with inoperable or persistent chronic thromboembolic pulmonary hypertension.Chronic thromboembolic pulmonary hypertensionMedDRA version: 21.1Level: PTClassification code 10064911Term: Pulmonary arterial hypertensionSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2019-004131-24-FRACTELION Pharmaceuticals Ltd.230
